Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.
Hørsholm, Denmark, 7 April 2026 - The Board of Directors of ExpreS2ion Biotech Holding AB (publ) ("ExpreS2ion" or the "Company") has today, on 7 April 2026, pursuant to the authorization granted by th ...
Prospectively designed for scalability and re-dosability, Immusoft’s engineered B cells represent the next generation of ...
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria. Approval in CSU for children two to ...
They decided to test their hypothesis with a drug known as JQ1. This drug was originally developed as a cancer treatment, and ...
On the shores of the west coast of Australia lies a window to our past: the stromatolites and microbial mats of Gathaagudu ...
On the shores of the west coast of Australia lies a window to our past: the stromatolites and microbial mats of Gathaagudu ...
Genomic analysis reveals squid and cuttlefish evolved in deep oceans, survived mass extinction in refuges, and later rapidly diversified, following a “long fuse” evolutionary pattern.
Unusually well-preserved fossils have provided the earliest known evidence of a land vertebrate that could pump air in and ...
A leading theory posits that life originated in prebiotic volcanic hot springs where the right mixture of elements, water, ...
The results are transforming how scholars understand human history. By analysing parchment, researchers are uncovering ...
Every breath you take is an ancient inheritance. The rise and fall of your chest, the intercostal muscles pulling your ribs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results